Serotonin-containing nerve fibres innervate cerebral blood vessels, but the source of this innervation and the physiological effects of perivascular serotonin re lease remain controversial, The purpose of the present study was to examine the effects of central serotonergic depletion upon the relationship between CBF and glucose utilization under both normo-and hypercapnic condi tions. To induce the loss of serotonergic terminals, rats were injected twice daily for 4 consecutive days with 20 mg/kg of the specific serotonergic neurotoxin methylene dioxyamphetamine (MDA). Between 4 and 6 weeks later, local CBF and glucose utilization were measured using the fully quantitative [14C]iodoantipyrine and [14C]2_ deoxyglucose auto radiographic techniques, respectively, and the efficacy of the lesioning protocol was assessed using [3H]paroxetine radio ligand binding analysis. In all animals treated with MDA, there was a significant de crease in serotonin uptake sites throughout the brain, fall ing from 223 ± 20 to 40 ± 16 fmol/mg tissue in parietal cortex, for example, although the raphe nuclei them-There is now compelling evidence that cerebral blood vessels are innervated by serotonergic neu rones arising from mesencephalic sites within the brain (Steinbusch, 198 1; Edvinsson et ai. , 1983; 
selves were unaffected (300 ± 20 fmol/mg tissue in con trols and 29 1 ± 18 in MDA-treated rats). In normocapnic rats, the effects of MDA pretreatment upon blood flow and glucose use were slight and focally concentrated. However, when the animals were rendered hypercapnic, CBF was significantly higher in MDA-treated rats than in normal controls, for example, increasing from 356 ± 22 ml 100 g-I min -I in frontal cortex of hypercapnic con trols to 700 ± 81 ml 100 g-I min-I in MDA-pretreated rats with similar levels of hypercapnia. In some brain areas of hypercapnic MDA-pretreated rats, blood flows were too high (>800 ml 100 g-I min-I) to be accurately quantified. The results of this study are consistent with a constrictor role for perivascular serotonergic innervation that becomes manifest when, as in hypercapnia, cere brovascular tone is low. Key Words: Cerebral blood flow-Cerebral glucose utilization-5-Hydroxytrypta mine-Hypercapnia-Methylenedioxyamphetamine Paroxetine binding. Scatton et ai., 1985; Bonvento et ai., 199 1) . These findings are not, however, uncontroversial (Cowan et ai., 1987; Jackowski et ai., 1989) , and the issue of serotonin (5-HT) uptake by perivascular sympa thetic nerves originating from the superior cervical ganglia continues to fuel debate (Moreno et ai., 1994) . Whatever the source of cerebrovascular se rotonergic innervation, 5-HT and its agonists are known to be profoundly vasoactive (Edvinsson et ai., 1978; Forster and Whalley, 198 1, 1982; Fu and Toda, 1983) , and 5-HT receptors have been identi fied on large cerebral arteries and pial arterioles (Miiller-Schweinitzer and Engel, 1983; Peroutka et ai., 1983; Hamel et ai., 1989) . The concept of an intrinsic central serotonergic effector mechanism by which changes in CBF may be coupled to alter ations in neuronal function may be an attractive proposition (Lou et aI., 1987) , but as yet there is no clear physiological evidence for such a role.
Despite the apparently widespread distribution of perivascular serotonergic innervation of central or igin (Duverger et aI., 1987; Bonvento et aI., 199 1) , intracerebral interventions to either stimulate (Bon vento et aI., 1989; Cudennec et aI., 1989) or induce specific serotonergic lesions (Dahlgren et aI., 198 1; McBean et aI., 1990a; Underwood et aI., 1992) have failed to provide a clear indication of the role played by 5-HT neurones in the control of CBF. Even when cerebrovascular tone is low (as in hypercap nia), and it might be anticipated that the loss of endogenous constrictor effects of 5-HT might be more clearly manifest (Rosenblum and Nelson, 1990) , the results are contradictory (ltakura et aI. , 1985; Underwood et aI., 1992) . The reasons for these inconsistencies are not clear but may lie in differences in measurement technique or anaes thetic regimens. The purpose of the present study was to apply quantitative autoradiographic tech niques to the investigation of effects of hypercapnia upon local cerebral blood flow (LCBF) and glucose utilization (LCMRglc) in the conscious rat brain fol lowing specific depletion of central serotonergic ter minals induced by the amphetamine derivative me thylenedioxyamphetamine (MDA).
METHODS

Animal treatment protocols
A total of 40 male Sprague-Dawley rats, weighing �50 g at the outset, were used in this study. The amphetamine derivative (± )-3 ,4-methylenedioxyamphetamine hydro chloride (MDA; Sigma) was dissolved in saline, and one group of rats (n = 20) were injected subcutaneously twice daily for 4 days with 20 mg/kg in a volume of 0.25 ml. Control rats (n = 20) were injected with saline alone. The rats were held under normal animal house conditions with free access to food and water for 4--6 weeks before the measurement of LCBF or LCMR gl c •
Animal preparation
On the day of the experiment, the animals (now weigh ing 250-300 g) were anaesthetised with halothane (main tained at 1% in a mixture of 70% nitrous oxide/30% oxy gen), and polythene cannulae were inserted into both femoral arteries, to allow sampling of arterial blood and the measurement of arterial blood pressure, and both femoral veins, for the injection of radiolabelled tracers and barbiturate at the time of killing. Following the ap plication of a loose-fitting plaster cast to the pelvis and hind limbs, the rats were supported on a weighted plat form to which the plaster was secured with adhesive tape and were placed into a polythene dome into which air was piped at a rate of 1.5 Llmin. The rats were allowed to recover from the effects of the anaesthesia for at least 2 h before any further experimental manipUlation, during which arterial pressure and rectal temperature were mon itored continuously. At the end of this recovery period, hypercapnia was induced in equal numbers of MDA-and saline-pretreated rats (n = 10 from each treatment group) by the introduction of carbon dioxide into the air supply until arterial Peoz tensions within the range of 55-65 mm Hg were attained. Normocapnic animals (n = 10 from each treatment group) continued to be supplied with air alone. Following a lO-min equilibrium period and at 5-min intervals over the subsequent 20 min, samples of arterial blood (80 fJ-l) were withdrawn for gas analysis (Corning 168 Gas Analyzer) to ensure constancy of CO2 tensions. The measurement of LCMR gl c was initiated at the end of the 10-min equilibrium period, whilst LCBF studies were initiated after 20 min. The time differential was chosen so that the measurement of LCBF coincided approximately with the median point of integrated specific 2-deoxyglu cose in the brain. For each of the LCBF and LCMR glC measurements, there were four different treatment groups, each with n = 5: normocapnia + saline pretreat ment; normocapnia + MDA pretreatment; hypercapnia + saline pretreatment; and hypercapnia + MDA pre treatment.
Measurement of LCBF
CBF was measured in 20 rats (5 from each treatment group) using the quantitative [14C]iodoantipyrine autora diographic technique (Sakurada et aI., 1978) . The tracer (50 f.1Ci/rat in 0.6 ml saline) was infused intravenously at a constantly accelerating rate over 45 s. Over the infusion period, blood was allowed to flow freely from one of the arterial cannulae and samples were collected intermit tently onto preweighed filter discs that were reweighed after the experiment to determine the sample size. Sub sequently, the timing of each sample was determined pre cisely from an audiocassette recording of the experiment and corrected for the flow characteristics of the cannula tubing. At 45 s, the animals were killed by the rapid in travenous injection of sodium pentobarbitone, and the brains were dissected intact and frozen in precooled 2-methylbutane (-4SOC) within 2-3 min of death. The filter discs were placed into scintillation vials and 0.4 ml hydrogen peroxide added to bleach the pigment prior to liquid scintillation analysis.
Measurement of LCMR g lc
Glucose use was measured in 20 rats (5 from each treat ment group) using the fully quantitative [14C]2-de oxyglucose autoradiographic technique (Sokoloff et aI., 1977) . The measurement was initiated with a 30-s intra venous injection of tracer (50 fJ-Ci/rat in 0.75 ml saline). Over the subsequent 45 min, a total of 14 timed arterial blood samples were collected at predetermined intervals. These samples were centrifuged to separate plasma from the cellular fraction. Aliquots of each plasma sample were taken for the determination of 14C concentrations (20 f.11) and glucose levels (10 f.1l) by liquid scintillation analysis and semiautomated glucose oxidase assay (Beckman), re spectively. At the end of the measurement period, the rats were killed and the brains prepared as for blood flow experiments.
Preparation and analysis of autoradiograms
Cryostat sections (20 f.1m) were cut in the coronal plane from each brain. Three consecutive sections were col lected from every 200 fJ-m throughout the brain from me-dulla to frontal cortex, mounted onto glass coverslips, and rapidly dried on a hotplate. Sections adjacent to those used for autoradiographic measurement of LCMRglc and LCBF were thaw-mounted onto gelatin-covered glass slides and stored at -70°C for subsequent [3H]paroxetine autoradiographic binding analysis of serotonergic (5-HT) uptake sites. The slide-mounted sections were prepared for [3H]paroxetine autoradiography according to the pro tocol described previously (Battaglia et aI., 1987) with the addition of preliminary wash procedures designed to re move 14C tracers from the tissue (Chalmers and McCul loch, 1989) . Sections were then incubated in buffer con taining a saturating concentration (250 pM) of [3H]parox etine. Nonspecific binding was defined in adjacent sections by [3H]paroxetine binding in the presence of 4 /l-M citalopram.
Analysis of C4C]2-deoxyglucose, C4Cliodoantipyrine, and [3H]paroxetine autoradiograms was performed using a computer-based image analysis system (Cambridge In struments Quantimet 970). Tissue isotope concentrations were measured from auto radiographic images of brain sections relative to appropriate 14C_ or 3H-containing stan dards (Amersham International) and LCMRglc or LCBF calculated using the operational equations for the tech niques (Sokoloff et aI., 1977; Sakurada et aI., 1978) . Mea surements were taken from 25 functionally diverse brain regions from each of the perfusion territories supplied by the major cerebral arteries. Specific [3H]paroxetine bind ing was determined by subtraction of image densities from total and nonspecific binding images.
Statistical analysis
Data were evaluated statistically by analysis of vari ance followed by post hoc Scheffe test to allow multiple comparisons. Acceptable levels of significance were set at p < 0.05. Some of the regional blood flow values gen erated in this study were above the limits of accurate quantification for the iodoantipyrine technique and were reported as >800 ml 100 g -1 min -1. This resulted in an incomplete data set that precluded the use of the rigor ous mode of statistical analysis of the flow-metabolism relationship developed for experiments of this design (McCulloch et aI., 1982) . To determine whether there were any differences in the overall relationship of LCBF to LCMRglc between treatment groups, we therefore ap plied the Mann-Whitney V test to the ratios of mean LCBF to mean LCMRglc for each of the brain areas.
RESULTS
Physiological variables
There were no significant differences in physio logical variables between saline-and MDA pretreated groups under either normocapnic or hy percapnic conditions (Table 1) , but within each treatment group, arterial Pco2 and pH were signif icantly increased and decreased, respectively, in rats breathing air supplemented with CO2, Arterial P02 was also significantly increased in these ani mals, most probably due to the increased respirato ry effort that accompanied the hypercapnia. Nei ther plasma glucose levels nor arterial blood pres sures were significantly affected by either MDA pretreatment or hypercapnia, suggesting that levels of stress in these animals were no higher than in controls.
Paroxetine binding autoradiography
The effects of MDA treatment upon the distribu tion of e H]paroxetine-labelled 5-HT uptake sites were clearly evident from visual inspection of the autoradiographic images. In control animals, e H] paroxetine binding was found throughout the brain, with highest densities evident in neocortex, hippo campus, and elements of the extrapyramidal system (Table 2 ). In keeping with our previously published observations (McBean et ai., 1990a,b) , repeated ex posure to MDA resulted in widespread and pro found reductions in e H]paroxetine binding. In neo cortex, for example, binding densities (Bm ax ) de- creased by between 50 and 90% following MDA treatment. In a few other areas, most notably in the raphe nuclei, binding levels were largely preserved ( Table 2) .
LCBF
In keeping with previously published data (Mc Bean et aI., 1990a), MDA pretreatment produced focal increases in LCBF (Table 3) . Hypercapnia in saline-pretreated rats produced global increases in blood flow, which were statistically significant in all but two brain regions (flocculus and median raphe) ( Table 3) . Similar global increases were evident in hypercapnic MDA-pretreated rats, but in the major ity of areas (20 of 25), LCBF was significantly higher than in saline-treated rats with similar levels of hypercapnia (Table 3) . Indeed, in every MDA pretreated rat, hypercapnia produced blood flows that in some areas were so high that it proved im possible to quantify them accurately. In these re gions, the values reported (800 mll00 g-I min-I) may be an underestimate (Table 3) .
LCMR g lc
In saline-pretreated rats, hypercapnia resulted in significant decreases in mean LCMRglc in 4 of the 25 brain areas analysed (Table 4 ). These brain regions were found exclusively within the motor system (cerebellum, striatum, and motor cortex), which is consistent with the reduced motor activity observed in these hypercapnic rats. Although a more general pattern of metabolic depression was evident in hy-percapnic rats previously exposed to MDA (Table  4) , this was against a pattern of widespread, though largely nonsignificant, increases in LCMRglc under normocapnic conditions. Apart from two areas (in ferior colliculus and visual cortex) in which the MDA-induced increase in LCMRglc was maintained with hypercapnia, there were no significant differ ences in LCMRglc between hypercapnic saline-and MDA-pretreated rats (Table 4 ).
Relationship between LCBF and LCMR g lc
In saline-treated rats, the ratio of LCBF to LCMRglc increased in every area of the brain under hypercapnic conditions (Table 5) , and over the brain as a whole, the ratios (median ratio = 4.38) were significantly greater than in normocapnic rats (median ratio = 1.97) (p = 0.00, Mann-Whitney U test). However, in the MDA-treated group under hypercapnic conditions, ratios of LCBF to LCMRglc were higher (median ratio = 6.00) than they were in intact hypercapnic controls, the only exceptions being the copula pyramis and white mat ter of the cerebellum and cingulate cortex (Table 5 ). Statistical analysis revealed that over the brain as a whole, the difference in ratios between intact and lesioned animals under hypercapnic conditions was highly significant (p = 0.0003, Mann-Whitney U test).
DISCUSSION
Although the neurotoxic properties of MDA have yet to be fully elucidated, it is clearly evident from immunohistochemical, neurochemical, and radioli gand binding studies that repeated exposure to MDA induces highly specific depletion of seroto nergic terminals in the rat brain whilst having no detectable effects upon either dopaminergic or nor adrenergic terminals (Battaglia et aI., 1987) . Neuro chemical indices of serotonergic terminal depletion induced by MDA (decreased 5-HT content and me tabolite concentrations) are paralleled both qualita tively and quantitatively by changes in the densities of e H]paroxetine-labelled 5-HT uptake sites (see Fig. 1) , and in the present study reductions of � 70% in paroxetine binding are similar to those reported previously using the same treatment regimen (Bat taglia et aI., 1987; McBean et aI., 1990a,b ). Whilst we were thus able to confirm the efficacy of our lesion relative to previously published accounts, with all the consequences for cerebral 5-HT sys tems which that entails, we did not have any direct measure of alterations in perivascular serotonergic processes. Although there is no a priori reason to expect that perivascular serotonergic fibres should react any different from those in the neuropil, in the 
All data are presented as mean LCBF (ml 100 g-: 1 min -1 ) ± SD. For each measurement grouP. n = 5. For abbreviations see text.
a Significantly different from appropriate saline-pretreatment group. b Significantly different from similarly pretreated normocapnic group, p < 0.05 (analysis of variance followed by post hoc Scheffe test for multiple comparisons).
absence of direct evidence, the possibility cannot be completely discounted, and any attempt to cor relate changes in local blood flow with changes in gross regional paroxetine binding must be treated with caution. Moreover, the paroxetine binding in this study will reflect to a large extent intraparen chymal terminal loss, and it is not surprising there fore that no such correlation appears to exist. This is most amply exemplified in the dorsal raphe nu cleus where paroxetine binding was unaffected by MDA pretreatment and yet blood flow under both normo-and hypercapnic conditions was signifi cantly higher than control. Numerous studies have shown 5-HT to be a po tent cerebrovascular constrictor, both in vitro (Toda et aI., 1976; Forster and Whalley, 1982; Fu and Toda, 1983) and in situ (Edvinsson et aI., 1977) . Although these studies examined large cerebral ar teries and pial arterioles, following circumvention of the blood-brain barrier, 5-HT administered sys temically produces reductions in CBF in the whole animal (Harper and MacKenzie, 1977; Grome and Harper, 1983) , which would be consistent with there being a similar serotonergic constrictor influ ence upon the resistance vessels. More recently, pharmacological inhibition of endogenous 5-HT re lease, by systemic application of an agonist specific for the 5-HT1A autoreceptor, was found to induce increases in LCBF that were in excess of any con comitant changes in LCMRglc in the physiologically normal rat (McBean et aI., 1991) . Moreover, local ized inhibition of 5-HT release with intracerebral injections of a 5-HT 1B agonist also increases CBF and produces focal flow-metabolism uncoupling (Kelly et aI., 1987) . Taken together, the results of these pharmacological studies are consistent with a perivascular serotonergic innervation providing vasoconstrictor tone throughout the cerebrovascu lar tree, from the major arteries to the intraparen chymal resistance vessels.
Although 5-HT may be taken up by perivascular sympathetic nerves innervating the large cerebral vessels (Saito and Lee, 1987) , it is not these that provide the principal resistance elements to the ce rebrovascular bed. This role is provided by the small arteries and arterioles, and there is evidence that the serotonergic nerve fibres associated with these vessels arise from the raphe nuclei (Edvins son et al., 1983; Scatton et al., 1985; Bonvento et al., 1991) . Given the pharmacological evidence for a tonic influence of this central serotonergic innerva tion upon the cerebral circulation, it is surprising that selective toxins directed at serotonergic nerves appear not to alter resting CBF to any great extent (McBean et al., 1990a) , if at all (Dahlgren et al., 1981; Underwood et al., 1992) . The results of the present study do, however, indicate that serotoner gic nerves may have a role to play in the regulation of LCBF under hypercapnic conditions and would be consistent with an intact serotonergic system providing a constrictor influence that moderates ce rebrovascular dilatation induced by hypercapnia. Such a limited physiological role for 5-HT would be in keeping with the constrictor influence of 5-HT being most pronounced in vessels with low tone (Edvinsson et al., 1977; Rosenblum and Nelson, 1990) , as will be the case with hypercapnia.
Although the results of this study are in keeping with previous measures of cortical blood flow fol-lowing serotonergic lesions (ltakura et al., 1985) , they are clearly not in agreement with the long standing observations of Dahlgren et al. (1981) , who showed that 5,7-DHT-induced serotonergic lesions had no effect upon hypercapnia-induced cerebro vascular dilatation, or the more recent results from Underwood et al. (1992) using electrolytic lesions. However, those studies were performed upon rats that were anaesthetised, paralysed, and artificially ventilated. The importance of anaesthetic effects in studies of this type has been highlighted recently (Edvinsson et al., 1993) , and these factors must rep resent a real concern in the interpretation of con flicting data.
In these studies we have provided evidence that hypercapnia-induced increases in blood flow are en hanced by the loss of 5-HT neurones, but the effect upon the flow-metabolism relationship arises from two contributory factors. Whilst hypercapnic LCBF in MDA-treated rats is higher than in �aline treated rats, LCMRglc is also decreased in a sub stantial proportion of the brain regions analysed, albeit to similar levels following both saline and MDA pretreatment. The literature on the metabolic response of the brain to hypercapnia is somewhat confused, with either no change (EkIOf et al., 1973; Artu and Michenfelder, 1980) or increased cerebral metabolism being reported (Berntman et al., 1979) . Although in this study hypercapnia-induced de creases in LCMRglc were observed in intact ani mals, the effects were limited to areas involved in motor function and are likely to have been second ary to the overall reduction in general motor activ ity, which, in these conscious animals, was ob served to accompany an increased respiratory ef fort.
The results of this study have clinical implica tions that may go beyond the sphere of cerebrovas cular research. The related amphetamine derivative methylenedioxymethamphetamine (MDMA; "Ec stasy") is a recreational drug used on a regular basis by growing numbers of individuals, and preliminary studies have indicated that the effects of MDA iden tified in this study are also shared by MDMA (Shar key et al., 1993) . The loss of cerebrovascular tone when an individual is physiologically challenged may have profound pathophysiological conse-J Cereb Blood Flow Metab, Vol. 15. No.4. 1995 FIG. 1. Autoradiographic images from coronal sections of rat brain at the level of the medial geniculate bodies illustrating the distributions of [3Hlparoxetine-labelled 5-HT uptake sites in a control rat (top) and in a rat pretreated with MDA 4 weeks previously (bottom). Note the contrast between high image densities in neocortex and hippocampus of control brain when compared with brain exposed to MDA, but also the relative sparing of binding in the nigral region of treated brain. For abbreviations see text.
quences and could be a contributory factor in the aetiology of cerebrovascular accidents reported from abusers of MDMA (Harries and DeSilva, 1992) .
